Title : The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators - Benchekroun_2016_J.Med.Chem_59_9967 |
Author(s) : Benchekroun M , Romero A , Egea J , Leon R , Michalska P , Buendia I , Jimeno ML , Jun D , Janockova J , Sepsova V , Soukup O , Bautista-Aguilera OM , Refouvelet B , Ouari O , Marco-Contelles J , Ismaili L |
Ref : Journal of Medicinal Chemistry , 59 :9967 , 2016 |
Abstract : Benchekroun_2016_J.Med.Chem_59_9967 |
ESTHER : Benchekroun_2016_J.Med.Chem_59_9967 |
PubMedSearch : Benchekroun_2016_J.Med.Chem_59_9967 |
PubMedID: 27736061 |
Benchekroun M, Romero A, Egea J, Leon R, Michalska P, Buendia I, Jimeno ML, Jun D, Janockova J, Sepsova V, Soukup O, Bautista-Aguilera OM, Refouvelet B, Ouari O, Marco-Contelles J, Ismaili L (2016)
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators
Journal of Medicinal Chemistry
59 :9967
Benchekroun M, Romero A, Egea J, Leon R, Michalska P, Buendia I, Jimeno ML, Jun D, Janockova J, Sepsova V, Soukup O, Bautista-Aguilera OM, Refouvelet B, Ouari O, Marco-Contelles J, Ismaili L (2016)
Journal of Medicinal Chemistry
59 :9967